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Abstract
Background:  RNA interference results in specific gene silencing by small-interfering RNAs
(siRNAs). Synthetic siRNAs provide a powerful tool for manipulating gene expression but high cost
suggests that novel siRNA production methods are desirable. Strong evolutionary conservation of
siRNA structure suggested that siRNAs will retain cross-species function and that transgenic plants
expressing heterologous siRNAs might serve as useful siRNA bioreactors. Here we report a
detailed evaluation of the above proposition and present evidence regarding structural features of
siRNAs extracted from plants.
Results: Testing the gene silencing capacity of plant-derived siRNAs in mammalian cells proved to
be very challenging and required partial siRNA purification and design of a highly sensitive assay.
Using the above assay we found that plant-derived siRNAs are ineffective for gene silencing in
mammalian cells. Plant-derived siRNAs are almost exclusively double-stranded and most likely
comprise a mixture of bona fide siRNAs and aberrant partially complementary duplexes. We also
provide indirect evidence that plant-derived siRNAs may contain a hitherto undetected
physiological modification, distinct from 3' terminal 2-O-methylation.
Conclusion: siRNAs produced from plant hairpin transgenes and extracted from plants are
ineffective for gene silencing in mammalian cells. Thus our findings establish that a previous claim
that transgenic plants offer a cost-effective, scalable and sustainable source of siRNAs is
unwarranted. Our results also indicate that the presence of aberrant siRNA duplexes and possibly
a plant-specific siRNA modification, compromises the gene silencing capacity of plant-derived
siRNAs in mammalian cells.
Background
RNA interference (RNAi) culminates in gene silencing via
the sequence specific action of small interfering RNAs
(siRNAs). Originally described in plants [1,2] as post tran-
scriptional gene silencing (PTGS), studies spanning the
animal and plant kingdoms have uncovered a broad con-
servation of RNAi [3-6]. RNAi has been extensively
reviewed [7-10] and the essential molecular mechanism
involves processing of double-stranded (ds) precursor
RNAs by a Dicer-like (DCL) endonuclease to produces
21–25 bp short interfering RNAs (siRNAs). Subsequently
the siRNA/DCL complex is converted to an active RNA-
induced silencing complex (RISC) containing the mRNA
anti-sense siRNA strand (the guide) and an Argonaute
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(Ago) protein. In one of the major RNAi pathways (the
RNA cleavage pathway) active RISC then performs a single
endonucleolytic cleavage of the target RNA as directed by
the guide siRNA.
RNAi has emerged as a powerful experimental tool and
the size, stability and specificity of siRNAs points to signif-
icant commercial and therapeutic potential [11,12]. The
discovery that synthetic siRNAs are competent for gene
silencing [13,14] has proven particularly useful in mam-
malian cells by circumventing the toxic effects elicited by
longer dsRNAs [15]. However while synthetic siRNAs are
readily obtained their use is impacted by high costs and
the variable potency of individual siRNAs. Use of recom-
binant Dicer to generate siRNA pools (Dsi) from larger
dsRNA precursors in vitro [16,17] overcomes the latter
problem but is still costly. It therefore remains of signifi-
cance to seek more economical, scalable and sustainable
methods for siRNA production. Exploitation of transgenic
organisms for production of biomolecules is increasingly
common and in this study we aimed to explore the poten-
tial of plants for heterologous siRNA production.
Besides small differences in size and their participation in
a wide range of siRNA functions [18-20], broadly con-
served siRNA structure suggests that siRNAs per se are
likely to be functionally equivalent. Thus siRNAs might be
expected to retain cross-species function but, for technical
reasons, this issue has yet to be rigorously explored. One
study [21] directly tested plant siRNAs in C. elegans and
concluded that gene silencing activity co-purifies with a
putative RNA species of approximately 80 nt. However, as
noted by the authors [21] the low concentration of plant
siRNAs present did not allow a conclusion concerning
siRNA functionality in the worm. Another consideration
is that due to asymmetric incorporation of double-
stranded siRNAs into RISC in vivo [10,22], siRNAs
extracted from plants might be single-stranded (as is the
case for microRNAs [23-25]) and hence much less active
[26]. Indirect cloning approaches [27] have provided
some evidence that plant siRNAs from hairpin transgenes
contain much single stranded siRNA but the siRNAs have
not been directly examined. Finally, although a recent
study concluded that plant-derived siRNAs are functional
for gene silencing in mammalian cells [28] the efficiency
of gene silencing was not established.
Here we report that siRNAs produced from plant hairpin
transgenes and extracted from plants are ineffective for
gene silencing in mammalian cells. Scalable and sustaina-
ble production of siRNAs cannot therefore be achieved
using the above approach. Our results also indicate that
the presence of aberrant siRNA duplexes and possibly a
plant-specific siRNA modification, compromises the
silencing capacity of plant-derived siRNAs in mammalian
cells.
Results
Expression of mouse caspase 9 siRNAs in transgenic plants
We aimed to evaluate whether siRNAs targeting a mam-
malian gene (mouse caspase 9, mc9) can be efficiently
produced in transgenic plants and whether such siRNAs
are competent for gene silencing in mammalian cells.
Transgenic tobacco plants were obtained as previously
described [28,29] using pBmC9 (Figure 1A). The expres-
sion cassette contained ~400 nt of caspase 9 sequence in
the sense orientation with the corresponding antisense
sequence downstream, separated by a natural intron that
is known to facilitate siRNA expression [28]. The primary
transcript is a 400 bp caspase 9 dsRNA stem that is recog-
nised by the plant PTGS machinery and processed to yield
a pool of siRNAs. Multiple kanamycin resistant/GUS pos-
itive plants (referred to as Tc9 #1, 3, 5, 9, 11 and 13) were
examined for integration of the siRNA expression cassette
by PCR of genomic DNA (Figure 1A). Transformants Tc9
#1, 3 and 5 contained an intact transgene while Tc9 #11
and 13 had only the anti-sense region and Tc9 #9 had pos-
sibly no transgene insertion at all. The above transform-
ants were screened for siRNA expression by Northern
blotting using a caspase 9 riboprobe (Figure 1A). Three of
six transformants (1, 3 and 5) expressed readily detectable
levels of caspase 9 RNA species that migrated slightly
faster than a 31 nt oligonucleotide marker. The other
transformants (9, 11 and 13) were negative (as was paren-
tal (wt) tobacco) as predicted by the lack of an intact
transgene. Thus we conclude that Tc9 #1, 3 and 5 express
the caspase 9 dsRNA precursor and efficiently produce a
pool of siRNAs (referred to as Tc9si).
To verify the functionality of Tc9si we co-infiltrated trans-
genic plants with expression vectors for caspase 9 and
EYFP RNAs (as control), isolated total plant RNA and
probed for caspase 9 and EYFP transcripts by Northern
blotting (Figure 1B). Caspase 9 transcripts were readily
detected in wt infiltrated plants but only very low levels
were detected in Tc9 Lines 1 and 3. EYFP transcripts were
detected at similar levels in both wt and Tc9 plants. From
the above results we conclude that Tc9 #1 and 3 express
functional siRNAs directed against caspase 9 and since Tc9
#1 shows the highest Tc9si level (Figure 1A) we used this
for Tc9si production.
Analysis of Tc9si by RNAse protection assay
Although Tc9si can be detected by Northern blotting the
signal tended to be quite variable and with low resolution.
We therefore employed a highly sensitive RNAse protec-
tion assay (RPA) and initially used a 21 nt caspase 9 siRNA
(c9si) to establish conditions. An ~200 nt 32P-labeled cas-
pase 9 riboprobe was hybridised with denatured c9si,Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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hybrids were treated with a limited amount of RNAses A/
T1 and protected fragments were resolved on a denaturing
polyacrylamide gel (Figure 2). A single c9si-dependent
band with a mobility consistent with ~21 nt was observed
with two smaller species that result from interaction of the
probe with carrier tRNA. Using RPA it is quite feasible to
detect as little as 10 pg of c9si, as reported by others
[30,31].
Because Tc9si contain many individual siRNAs each with
different efficacy it is not appropriate (for the gene silenc-
ing assays described later) to compare Tc9si with a single
synthetic siRNA such as c9si. As a positive control we
therefore used human recombinant Dicer [16,17] to pro-
duce siRNA pools (Dc9si) in vitro from the same caspase
9 target region used to create Tc9 plants. Dicer was used to
produce Dc9si followed by RPA analysis. The Dc9si sam-
ple yielded several products in the size range of 22–25 nt
(Figure 2) as expected and similar to but broader than
Generation of transgenic tobacco expressing mC9 siRNAs Figure 1
Generation of transgenic tobacco expressing mC9 siRNAs. (A) mC9 transgene and siRNA expression. The mC9 
siRNA cassette contains 400 bp mC9 sense and anti-sense sequences separated by the TGA1 intron (I) with expression by the 
CMV 35S promoter (35S) and NOS terminator. Transgene integrity for plants Tc9 #1, 3, 5, 9, 11, 13 was verified via PCR 
(primer position indicated by black arrows) to detect sense (s) and anti-sense (as) transgene elements. Endogenous rbcL is 
control. For siRNA expression 30 μg of total RNA from wt tobacco or Tc9 transformants was analysed by Northern blotting. 
A 31 nt mC9 DNA oligo (m) is size marker and an overnight phosphor-image is shown. (B) In vivo gene silencing in Tc9 trans-
formants. Transient transformation was performed by co-infiltration of tobacco wt, Tc9 #1 and #3 with plasmids expressing 
mC9 sense (pBmC9s) and EYFP transcripts (pBEYFP). Transcript levels in leaf regions were analysed 48 hr post-infiltration by 
Northern blotting (as described in materials and methods).Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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siRNA detection by RNase Protection Assay (RPA) Figure 2
siRNA detection by RNase Protection Assay (RPA). Synthetic mC9 siRNA (c9si) and different sources of RNA were 
probed by RPA (top) using a mouse caspase 9 anti-sense probe. The positions of intact 32P-labeled probe (~200 nt), siRNAs, 
xylene cyanol (XC, ~60 bp) and bromophenol blue (BPB, ~15 bp) are indicated. tR (yeast tRNA); Gsi (GAPDH synthetic 
siRNA); c9si (single mC9 synthetic siRNA); Tc9 1 and 2 (total RNA samples from two Tc9 plants); WT (total RNA from wt 
plant); Dc9 (Dicer-derived mC9 siRNA); BL (body-labeled Dicer siRNA). Bands marked Δ are artifacts of the RPA as described 
in the text. Quantitation of Dc9si (bottom) was achieved by comparison with known amounts of synthetic siRNAs following 
resolution on 15% non-denaturing PAGE gels and staining with EtBr.Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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Dc9si that were directly body-labeled (BL) using radioac-
tive UTP in the in vitro transcription reaction. Dc9si also
produced some additional slower migrating species
(marked Δ in the figure) but these are absent in BL and
therefore appear to be an artifact of the RPA. Dc9si were
quantified by comparison with known amounts of syn-
thetic siRNAs after ethidium bromide staining (Figure 2).
Analysis of total RNA samples from Tc9 plants showed a
pattern of protected fragments very similar or identical to
that obtained for Dc9si and that were absent in RNA sam-
ples from parental (wt) plants (Figure 2). The RPA there-
fore faithfully detects Tc9si present in total plant RNA
samples. In addition the RPA assay readily allows detec-
tion of larger dsRNA precursors but for several tobacco
RNA samples (including those shown in Figure 2) none
were detected. Thus dsRNA processing from transgenes
appears to be highly efficient in tobacco and allows for
direct testing of total plant RNA in mammalian cells with-
out concern for PKR activation that would be brought
about by longer unprocessed dsRNAs [15].
Efficiency of plant siRNA production
We employed TRIzol reagent (Invitrogen) for plant RNA
extraction and optimised the amount of TRIzol required
(see materials and methods). Optimised TRIzol extraction
gave ~50 ng of Tc9si/340 μg of total RNA/g of tobacco leaf
(as determined by RPA of Tc9si and known amounts of
Dc9si) equating to ~1.5% by mass compared with total
plant mRNA. Similar siRNA levels were produced by
transgenic tomato fruit (data not shown) and agree with
expectations based on CaMV 35S-driven protein expres-
sion plants [32]. We also calculate that the cost of plant
siRNA production is broadly comparable with that for in
vitro-generated siRNA pools (produced by recombinant
Dicer) but much greater than that for single synthetic siR-
NAs (data not shown).
A rapid small scale silencing assay for Tc9si
Given the yield of Tc9si we anticipated that a small scale
mammalian gene silencing assay would be required for
functional testing. We found that Lipofectamine2000
(Clontech) mediated co-transfection of BalbC-3T3 cells
with an EGFP siRNA (Esi) and expression vectors for EGFP
and a caspase 9-EGFP fusion protein (c9EGFP) (Figure 3)
enabled sensitive monitoring of silencing via Western
blotting with EGFP antibody (JL8, Clontech). Under the
conditions tested Esi was highly effective (at 4 nM) at
silencing both EGFP and the c9EGFP fusion.
Before testing Tc9si we first established conditions for
gene silencing by gel-purified Dc9si (Figure 3). Addition
of gel purified Dc9si during transfection efficiently
reduced c9EGFP protein levels without any effect on
EGFP, while the same amount of an unrelated Dicer-gen-
erated GAPDH siRNA (DGsi) had no effect. 9 nM Dc9si
was sufficient to almost eliminate c9EGFP expression,
while 5 nM (corresponding to 3 ng of Dc9si per well) was
very effective and 3 nM had a significant although weaker
effect. We conclude that Dc9si are very effective at silenc-
ing the c9EGFP target under the assay conditions
employed and that silencing can readily be monitored
using 5 nM Dc9si.
In light of the relatively low abundance of Tc9si in total
plant RNA samples and several other technical challenges
(see Figure 4) the small scale, rapidity and robustness of
the above assay greatly facilitated experiments with plant
materials that were cubersome to produce. In addition
early microscopic monitoring of EGFP expression from
the control vector just a few hours post-transfection (Fig-
ure 3) was expeditious for problem solving during trial
experiments.
Tc9si activity in mammalian cells
Using the above assay we attempted to test Tc9si for
silencing activity (Figure 4) but found that Tc9 total RNA
(or total RNA from tomato, data not shown) almost elim-
inated expression of c9EGFP and EGFP (Figure 4A). The
same effect was observed using other cells (HeLa, data not
shown) and other transfection reagents including Code-
breaker and RNAifect (Figure 4A) and there was no effect
of Tc9 RNA on endogenous β-actin levels (data not
shown). As little as 100 ng of yeast tRNA mimicked the
inhibitory effect of the Tc9 RNA sample indicating that
plant RNA is most likely responsible for the inhibition.
To try and overcome the above problem we gel purified
Tc9si (Tc9p) as described for Dc9si but this did not
remove the inhibitory effect (Figure 4A). Since plant RNA
preparations are often contaminated with polysaccharides
and polyphenolic compounds we next treated purified
Tc9si sample with 200 mM KOAc to remove putative con-
taminating polysaccharides [33] and found that this elim-
inated the inhibitory effect (Figure 4B, left hand panel).
Surprisingly however the Tc9si sample had no silencing
activity despite containing easily sufficient c9siRNA as
assessed by RPA. KOAc does not reduce silencing by Dc9si
and, most importantly, the Tc9si sample has no inhibitory
effect on silencing by Dc9si. Polyvinylpyrrolidone (PVP)
has been shown to overcome the inhibitory effect of
polyphenolic compounds on certain reactions, such as
rtPCR, involving plant RNA [34]. We therefore treated the
Tc9 sample with PVP but found that this did not lead to
activation of the Tc9si sample (Figure 4B). We also tested
up to 10 nM Tc9si (for technical reasons we could not
assay higher concentrations) and observed no silencing
activity (data not shown). The above data indicate a sub-
stantial difference in the activity of Dc9si (3 nM is activePlant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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and 10 nM is very potent, Figure 3) versus Tc9si (10 nM is
not active).
The gel purified Tc9si sample contains a significant
amount of endogenous small RNAs, including microR-
NAs [35,36] that might interfere with silencing by com-
peting with Tc9si for a limiting amount of RISC [37]. To
examine the above possibility we first prepared gel-puri-
fied plant small RNAs (Total small RNAs or TsRNAs) from
wt plants and assessed the amount of contaminating TsR-
NAs present in the Tc9si sample. Quantitation of TsRNAs
by comparison with known amounts of siRNA by ethid-
ium bromide staining (as described for quantitation of
Dc9si) and estimation of Tc9si by RPA, showed that there
is a ~10:1 ratio of TsRNAs : Tc9si and thus the silencing
assays contain ~30 ng of TsRNAs and 3 ng of Tc9si. How-
ever, testing of TsRNA up to 40 ng in the silencing assay
does not inhibit silencing by 3 ng of Dc9si (Figure 4C). To
further evaluate the presence of putative si/miRNA inhib-
itors in the Tc9si sample we tested the effect of a synthetic
GAPDH siRNA (Gsi) on silencing by EGFP siRNA (Esi).
Up to 30 ng of Gsi has no effect on EGFP silencing while
300 ng of Gsi still allows some silencing (Figure 4C). The
above competition analyses demonstrate that lack of
silencing by Tc9si is not due to inhibition by a contami-
nating component within Tc9si that competes for limiting
RISC.
Although competent for nucleic acid hybridisation (as
shown by RPA) it remained possible that Tc9si may be
chemically damaged during preparation in a manner that
impairs gene silencing. To test this we mixed Dc9si with a
plant RNA extract at the first step of RNA preparation,
recovered and quantified the treated Dc9si (referred to as
Dc9si*, Figure 4D) and tested for silencing activity.
Dc9si*retained full silencing activity and we therefore con-
clude that the procedure for Tc9si isolation does not inac-
tive Tc9si.
Finally because siRNAs can be degraded by serum nucle-
ases [38] we tested the effect of serum treatment on the
Dc9si and Tc9si samples (Figure 4E) to verify that the
inactivity of Tc9si is not due to instability in tissue culture.
Serum treatment of Dc9si produced a gel mobility shift on
Mammalian cell gene silencing assay Figure 3
Mammalian cell gene silencing assay. Mouse BalbC 3T3 cells in a 24-well tissue culture plate format were transfected 
with equal amounts (500 ng each) of expression vectors for EGFP (pdsEGFP) and a mouse caspase 9/EGFP fusion (pmC9-
dsEGFP) in the presence of the indicated concentrations (nM) of siRNAs. The fluorescent image (top) shows EGFP/c9EGFP 
expression in transfected cells. siRNAs used are as follows: Dc9si (gel purified Dicer-generated caspase 9); DGsi (gel purified 
Dicer-generated GAPDH); Esi (synthetic EGFP siRNA). DGsi/DGsi1 and Dc9si/Dc9si1 refer to two different siRNA prepara-
tions. Silencing was assessed at 16 hours post-transfection by Western blotting using EGFP antibody and 15% of the protein 
extract from a single well of the tissue culture plate (as described in materials and methods).Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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Testing plant-derived siRNAs in mammalian cells Figure 4
Testing plant-derived siRNAs in mammalian cells. (A) Testing plant siRNAs for gene silencing. Gene silencing assays 
were performed in 96 well plate format. Cells were co-transfected with pmC9-dsEGFP and pdsEGFP (70 ng each) together 
with 18 μg of total Tc9 RNA (Tc9), 10 μg of total tomato RNA (Tom), gel purified Tc9 small RNAs (Tc9p) contributing 5 nM 
Tc9si or tRNA (amount indicated in ng) using Lipofectamine 2000 (Lipo2000), Code Breaker (CB) or RNAiFect (RF) transfec-
tion reagents. (B) Effect of KOAc and PVP treatment. Left Hand Side. Silencing assays contained 3 ng of gel-purified Dc9si and 
Tc9 small RNAs containing 3 ng of Tc9si that had been pre-treated (or not) with 200 mM KOAc (see materials and methods). 
Right Hand Side. Assays were performed with 3 ng of KOAc treated siRNA samples in the presence and absence of 2% Polyvi-
nylpyrrolidone (PVP) (see materials and methods). (C) Effect of other small RNAs on gene silencing. Left Hand Side. Silencing 
assays were performed with increasing amounts (indicated in ng) of gel-purified small RNAs (TsRNAs) from wt tobacco plants 
together with Dc9si. Right Hand Side. Cells were co-transfected with pdsEGFP only and one amount of Esi (12 ng) together 
with increasing amounts of a synthetic GAPDH siRNA (Gsi). (D) Effect of plant small RNA preparation protocol on Dc9si 
activity. Dc9si was mixed into the tobacco wt plant sample (at 50 ng/g of leaf) during the RNA extraction process. Extracted 
RNAs were gel purified and recovered Dc9si (Dc9si*) was quantitated by RPA (right panel). For silencing assays, cells were co-
transfected with pmC9-dsEGFP and pdsEGFP with 3 ng of Dc9si or 3 ng of two different preparations of Dc9si*. (E) Effect of 
RNase digestion and serum treatment on siRNAs. Left hand side. Unlabeled Dc9si and 32P-body-labeled Dc9si (BL) were 
treated (treated (+) or untreated (-)) with a limited amount of RNAses as described in materials and methods. Dc9si was 
detected by RPA and BL Dc9si was detected directly on the same gel. 32P-end labeled synthetic RNA oligonucleotides of 25 
and 21 nt are size markers. For serum treatment (right hand side), Dc9si and Tc9si were treated with FBS (see materials and 
methods) for the indicated times. FBS treated products were detected by RPA.Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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denaturing gels similar to that observed for digestion with
low amounts of RNAseA/T1 and consistent with a limited
"exonucleolytic" cleavage (as described below) while
Tc9si present in the gel purified sample is actually resist-
ant to limited digestion by serum nucleases (Figure 4E).
We conclude that lack of gene silencing by Tc9si is not due
to instability of Tc9si in cell culture. From all of the above
control experiments we conclude that siRNAs extracted
from plants are insufficient for gene silencing in mamma-
lian cells.
siRNAs extracted from plants are in duplex form
In the asymmetric RISC formation process in vivo [10,22]
only one strand of each siRNA is retained in active RISC
while the other strand is degraded. This suggested that siR-
NAs extracted from plants might be predominantly single
stranded thus explaining their lack of gene silencing activ-
ity [26] and we therefore determined the proportion of
single-stranded siRNAs in Tc9si and Dc9si. siRNAs were
heat-denatured and resolved on a non-denaturing poly-
acrylamide gel together with a 32P-labeled synthetic siR-
NAs to provide a marker for single and double-stranded
siRNAs (Figure 5). RNAs were eluted from different
regions of the gel and detected by RPA under denaturing
conditions. The results show that Tc9si and Dc9si samples
are very similar and that the majority of Tc9si are double-
stranded with barely detectable levels of single-stranded
siRNA (Figure 5). Thus lack of gene silencing by Tc9si in
mammalian cells is not due to the presence of high
amounts of single-stranded Tc9si RNAs. The extent to
which the double-stranded RNAs present in the Tc9si
sample represent bona fide siRNAs is, however, not estab-
lished by our experiment (see discussion).
Effect of siRNA 3'-2-O-methylation on mammalian gene 
silencing
All classes of Arabidopsis [39] and tobacco [40] siRNAs
appear to have 3' terminal 2-O methylations and many
studies have tested the silencing activity of methylated
siRNAs in mammalian cells [38,41-43]. In one case [43] a
single 3' 2-O methylation had no effect on silencing
although this was under high siRNA concentration (100
nM) which might mask sub-optimal activity [37,44]. We
therefore tested a synthetic 3' 2-O methylated EGFPsiRNA
(mEsi) and the corresponding unmethylated control (Esi)
under stringent assay conditions (4 nM siRNA) and found
no obvious effect of methylation on the efficiency of
silencing (Figure 6). Thus 3' 2-O methylation of siRNAs in
planta does not appear to explain the lack of silencing
activity observed for Tc9si in mammalian cells.
Putative physiological modification of Tc9si
In light of the above result for methylated siRNAs we
probed for evidence of additional structural modification
of Tc9si. RPA analysis (Figure 2) showed no obvious size
difference between Dc9si and Tc9si but to better calibrate
Detection of double- and single-stranded siRNAs Figure 5
Detection of double- and single-stranded siRNAs. 32P-end labeled double-stranded siRNA (-) was heat denatured (+) 
and run on a non-denaturing polyacrylamide gel to provide mobility markers for ds and ss siRNAs (left hand side). Gel-purified 
Tc9si and Dc9si were heat denatured and separated on a non-denaturing gel along with the mobility markers described above. 
Regions of the gel marked 1–5 (left hand side) and containing Tc9si and Dc9si were excised, RNA recovered and detected by 
ribonuclease protection assay on denaturing gels (right hand side). Gel slice number is indicated at the top and heat treatment 
to the right.Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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the size range we ran 32P-labeled 21 nt and 25 nt siRNA
size markers and treated Dc9si with limiting amounts of
RNase A and T1 (Figure 4E). This produced a discreet
increase in mobility of 2–3 nt for Dc9si, consistent with
selective digestion of single stranded siRNA overhangs as
previously described [30]. Thus limited digestion of siR-
NAs with endonucleases (such as RNAseA/T1 or those
reportedly present in serum [38]) appears to be exonucle-
olytic due to the resistant double stranded body of the
siRNA. Nuclease treatment of body-labeled Dsi (BL) pro-
duced a very similar pattern of bands (Figure 4E). The
above experiment shows that RPA readily distinguishes
2–3 nt size differences and by comparing Dc9si and Tc9si
(Figure 2) we conclude that there is no significant size dif-
ference between Dc9si and Tc9si.
In denaturing urea gels the products observed following
RPA are derived only from the 32P-labeled riboprobe. We
reasoned that analysis on non-denaturing gels, in which
the probe/plant siRNA heteroduplex would remain intact,
might reveal conformational and hence structural differ-
ences between Dc9si and Tc9si. RPA was performed as
usual except that samples were not heated and were
resolved on a polyacrylamide gel under non-denaturing
conditions (Figure 7). The gel pattern observed for Dc9si
was multiple diffuse bands with no obvious bias, whereas
in contrast, Tc9si exhibited a predominant slower migrat-
ing species that accounts for the major portion of the
siRNA. A reproducible pattern was obtained for different
Tc9si samples and for siRNAs from tomato (data not
shown). To confirm that the altered Tc9si gel mobility was
not caused during RNA preparation, we examined Dc9si*
siRNAs (as described in Figure 4) and found that the pro-
file of bands for Dc9si* on non-denaturing gels was not
obviously altered (Figure 7). The above results suggest
that the decreased gel mobility of probe/Tc9si hybrids in
non-denaturing gels may reflect physiological modifica-
tion of a substantial fraction of Tc9si. We note that the
Dc9si sample contains a band of similar migration to the
putative modified species from plants. While this might
conceivably reflect an siRNA modifying activity of Dicer,
it seems more likely that the Dicer-generated band simply
comigrates with the putative modified plant siRNA. Thus
we suggest that the putative modifying activity is plant-
specific.
To assess whether a single 3'-2-O-methylation could
account for the altered mobility of plant siRNAs in non-
denaturing gels, we analysed Esi and mEsi siRNAs (Figure
7). Under a range of RNAse digestion conditions Esi- and
mEsi-probe complexes showed no difference in migration
relative to each other, indicating no effect of methylation
on siRNA mobility under non-denaturing gel conditions.
The above result indicates that 3'-2-O-methylation does
Structure of plant-derived siRNAs Figure 7
Structure of plant-derived siRNAs. Analysis of siRNA by RPA on non-denaturing gels. Native RPA products from single 
synthetic c9si (o), Dc9si and three different Tc9 total RNA samples were analysed on a 15% non-denaturing PAGE gel (left 
hand side). Dc9si* that had been subjected to the Tc9 RNA extraction and purification regime (as described in Figure 4D) was 
also examined. Esi (-) or mEsi (m) (right hand side) were subjected to RPA analysis using increasing amounts of RNAses as indi-
cated.
Effect of siRNA methylation on gene silencing Figure 6
Effect of siRNA methylation on gene silencing. EGFP 
(Esi) and 3'-2-O methylated EGFP (mEsi) siRNAs were tested 
for gene silencing using a co-transfected EGFP target and the 
indicated concentrations of siRNAs. Endogenous β-Actin 
served as negative control.Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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not account for the altered gel mobility observed for T9si,
suggesting that Tc9si may harbour a hitherto undetected
siRNA modification.
Discussion
Transgenic plants as siRNA bioreactors
Compared with efficient gene silencing achieved by Dc9si,
Tc9si show no activity in mammalian cells and we have
performed a range of controls to show that the lack of
activity is intrinsic to the siRNAs present in Tc9si. For tech-
nical reasons related to siRNA yield and purity we were
unable to test concentrations of Tc9si (100 nM) that are
often used for gene silencing experiments. It therefore
remains possible, or even likely, that the Tc9si population
is not totally inactive but rather, contains a mixture of spe-
cies (see below) that exhibit low overall silencing activity.
In any event potent siRNAs are effective at 1 nM [37] and
use of siRNA concentrations higher than 25 nM may elicit
significant off-target effects [37,44] and thus we have
shown that siRNAs present in the Tc9si sample are inop-
erative for gene silencing in mammalian cells under strin-
gent conditions. Complexity of the Tc9si RNA produced
from the ~400 bp dsRNA precursor is probably quite high
(see below) and simpler siRNA pools (from 100–150 bp
precursors) exhibit similar silencing activity [45]. Thus the
difference in silencing activity between the Tc9 and Dc9
siRNA pools seems unlikely to be accounted for by the
particular siRNA sequences present.
Our conclusions are in striking contrast to those of a pre-
vious report [28] which claimed that plant-derived siR-
NAs can provide a sustainable source of siRNAs for use in
mammalian cells/organisms. However, consistent with
our findings, the efficacy of plant-derived siRNAs previ-
ously reported appeared to be poor [28] when compared
with effective positive control siRNAs [46]. Thus it is
apparent that transgenic plants offer no obvious advan-
tages over established methodologies for siRNA produc-
tion.
At the outset of our study, short term use of siRNA pools
for gene silencing was attractive because it eliminates the
need to screen for effective single siRNAs. However
advances in RNAi methodology now indicate that siRNA
pools have significant limitations. One concern that the
bigger the pool size the higher the chance of off-target
effects in mammalian cells [37,44,47,48]. Secondly,
longer (~27 bp) synthetic siRNAs (which are not pro-
duced in planta) are extremely potent [49] apparently
because coupling to Dicer allows more efficient RISC for-
mation [49,50]. In summary the best approach for large
scale RNAi application now appears to be identification of
potent, elongated synthetic siRNAs and not the use of
siRNA pools.
Structure of siRNAs derived from plant transgenes
There are different size classes of plant siRNAs [30,51,52]
which might have differential function in mammalian
cells. However, the size distribution of siRNAs for the
Tc9si and Dc9si samples is not obviously different, indi-
cating that siRNA size does not account for the lack of
Tc9si function in mammalian cells. The broad siRNA size
range within the Tc9si sample is probably explained as
follows. We have used a 400 nt hairpin dsRNA that might,
minimally, be expected to yield 20–40 different siRNAs.
However there is microheterogeneity for processing of
long dsRNAs [45] and multiple Dicers (DCL2, DCL3 and
DCL4) are able to produce siRNAs from hairpin-trans-
genes in planta [53]. Thus the sequence complexity of the
Tc9si population may be quite high.
Asymmetric incorporation of siRNA strands into RISC
[10,22] and data from siRNA cloning [27] suggest that
siRNAs extracted from plants might contain significant
amounts of single-stranded siRNAs. In addition multiple
plant Dicers produce overlapping siRNAs from hairpin
transgenes [53] suggesting that Tc9si will contain a por-
tion of aberrant (non-functional) siRNA duplexes derived
from distinct parents. However if stringent asymmetric
RISC assembly applies then for any given pair of overlap-
ping siRNAs, complementary strands will occur only 50%
of the time and thus extracted siRNAs would be expected
to contain significant amounts of single stranded siRNAs.
Because our direct analysis of the Tc9si sample (Figure 5)
did not detect appreciable amounts of single-stranded siR-
NAs, we therefore interpret this to indicate that a signifi-
cant portion of the Tc9si RNAs are bona fide double-
stranded siRNAs. This interpretation is consistent with
genome scale smRNA sequencing analysis [54] suggesting
that plants do not strictly follow the siRNA asymmetry
rules. Considering all of the above it is most likely that the
Tc9si sample harbors a mixture of aberrant and normal
siRNAs.
Several factors could account for accumulation of a certain
level of double-stranded siRNAs in the Tc9si sample.
Firstly, similar to mammalian RISC [37] plant RISC is
likely to be readily saturated. Second, siRNA production
from CMV 35S-driven hairpin transgenes is very high (for
example > 50-fold higher than that driven by a moder-
ately active endogenous promoter [55]) thus saturating
RISC and leading to accumulation of double-stranded siR-
NAs. In support of this suggestion, hairpin transgene
processing operates through the viral defence pathway
[53] and siRNAs extracted from virally-infected plants are,
at least in some cases, double-stranded [56].
Recently it has been shown that, similar to plant miRNAs
[57], all classes of siRNAs in Arabidopsis undergo HEN1-
dependent 3' terminal 2-O methylation [39] which pro-Plant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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tects against nucleolytic degradation. Similarly a large
fraction (~90%) of tobacco siRNAs have a 2-O modifica-
tion (presumably methylation) of the 3' terminal ribose
[40]. Our results (Figure 7) provide indirect evidence for
an siRNA modification in addition to methylation, at least
for siRNAs produced from plant transgenes. Proof of the
putative plant-specific modification will depend on direct
structural analysis.
Function of plant siRNAs in mammalian cells
The previous finding that modified siRNAs can act as effi-
cient stoichiometric RNAi inhibitors [37] and that Tc9si
do not inhibit silencing by Dc9si (our study) suggests that
Tc9si may not compete for RISC formation. This may indi-
cate that Tc9si do not efficiently enter the mammalian
gene silencing pathway. Ago2 (the mammalian slicer)
interacts with the siRNA 3' overhang [58,59] and siRNA 3'
2-O methylation reduces Ago2/siRNA interaction [58].
However we have shown that (under stringent condi-
tions) 3' 2-O siRNA methylation is not inhibitory to
mammalian gene silencing and thus the effect of methyl-
ation on Ago2/siRNA interaction does not appear to com-
promise plant siRNA function in mammalian cells.
The ineffectiveness of Tc9si in mammalian cells might be
explained by the presence of a significant proportion of
aberrant siRNA duplexes (see above) together with the
fact that we were unable to assay high concentrations of
Tc9si (for the reasons mentioned above). It is also possi-
ble that the putative plant siRNA modification that we
have proposed might reduce Tc9si activity in mammalian
cells. In light of the complexity and diversity of plant
RNAi signaling [7,60,61], involving multiple DCL (DCL1-
4) and Ago family members [62], it is reasonable to sug-
gest that siRNAs may contain structural features (other
than size) that could directly contribute to specialisation.
In relation to the above possibility, it would be of interest
to examine whether specific plant DCL or Ago proteins
[63] might be able to bridge the apparent gap between
mammalian gene silencing components and plant siR-
NAs. Such experiments might provide important insights




Plasmid pBmC9 (Figure 1A) for creation of transgenic
plants and expression of siRNA pools from an ~400 bp
long hairpin precursor was designed as previously
described [28,29]. pBmC9s is related to pBmC9 but lacks
the TGA1 intron [64] and mC9 antisense sequence and
therefore expresses an 400 bp mC9 sense transcript.
pEYFP-T2m expresses the EYFP protein in plants [65].
pBSmC9 contains the entire mouse caspase 9 cDNA
sequence inserted into the polylinker of pBluescript SKII(-
). pmC9-dsEGFP expresses a caspase 9/dsEGFP fusion
protein containing the n-terminal 100 residues of mC9
fused to EGFP and was obtained as follows. pdsEGFP
expresses dsEGFP and was derived from pmC9-dsEGFP.
Generation and characterisation of transgenic tobacco
pBmC9 was introduced into tobacco (cultivar Samsun
NN) via standard Agrobacterium-mediated transforma-
tion as described [28] using Agrobacterium strain
GV3101/MP90 [66] and the leaf-disc procedure [67]. Pri-
mary transformants were first screened for GUS expres-
sion by leaf staining and transgene insertion was
confirmed by PCR analysis of genomic DNA. Selected
transformants were then tested for siRNA expression by
Northern blotting (Figure 1).
Preparation of plant total RNA and gene silencing in 
planta
RNA was originally prepared using TRIzol reagent (Invit-
rogen) according to the suppliers protocol except that
much less TRIzol was used. Since TRIzol is the major cost
factor for plant siRNA preparation we optimised the proc-
ess and found that for a fixed volume of TRIzol, siRNA
yield was proportional to the amount of leaf material
below ~4 g of leaf/ml TRIzol. Accordingly a ratio of 1 ml
TRIzol per 4 g leaf material (much less TRIzol than the
suppliers recommendation) was used for larger scale
siRNA extractions. For transient gene silencing assays in
tobacco, leaves were infiltrated by injection of trans-
formed Agrobacteria as previously described [28], total
RNA was prepared 48 hours later and Northern blotting
was performed using 20 μg of RNA.
siRNA detection
Northern blotting [68] and RNase Protection Assays
(RPA) [69] were carried out essentially as described else-
where. For RPA a 32P-labeled anti-sense probe spanning
~200 nucleotides of the mC9 RNA sequence expressed in
transgenic plants were prepared from linearised pBSmC9
and gel purified. Hybridisations contained 2 μl of RNA
sample, 1 μl RNA probe (approximately 1% of the mate-
rial obtained from in vitro transcription of 1 μg of a
pBSmC9), 3 μl of 10× buffer (4 M NaCl, 400 mM Pipes
pH 6.4, l0 mM EDTA) and deionized formamide in a total
volume of 30 μl. Samples were denatured at 85°C for 10
minutes and then incubated at 45°C overnight. The mix-
ture was treated at 30°C for 20 minutes with 20 μg/ml
RNase A and 1 μg/ml RNase T1 following addition of 350
μl digestion buffer (l0 mM Tris pH 7.5, 5 mM EDTA and
300 mM NaCl). Reactions were stopped with SDS and
proteinase K treatment, extracted with phenol/chloro-
form and the nucleic acid precipitated with ethanol after
addition of 15 μg tRNA. Samples were then analysed on
denaturing polyacrylamide gels. For non-denaturing gel
analysis, after RNase protection, samples were loadedPlant Methods 2007, 3:13 http://www.plantmethods.com/content/3/1/13
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directly onto the gel by addition of 6× gel-loading buffer
containing bromophenol blue, xylene cyanol and 30%
glycerol.
siRNA purification and quantitation
Small plant RNAs (TsRNAs) and DsiRNAs (Dsi) were
purified from 15% non denaturing polyacrylamide gel.
RNAs co-migrating with Dsi as were eluted in 350 μl depc-
treated water at 37°C overnight, recovered by ethanol pre-
cipitation and resuspended in depc-treated water. The
amount of Dsi was determined by ethidium bromide
staining of 15% non denaturing polyacrylamide gels and
by comparison with known amounts of synthetic siRNAs.
Specific plant siRNAs (Tc9si) were then estimated by RPA
and comparison with Dsi. For polysaccharide removal,
siRNA samples were adjusted to 200 mM potassium ace-
tate, incubated on ice for 30 minutes and then centrifuged
for 30 minutes at 12,000 g in an Eppendorf microcentri-
fuge in the cold room. A clear pellet was observed and the
supernatant (containing the siRNA) carefully removed.
Polyvinylpyrrolidone (PVP) treatment was performed by
including 2% water soluble PVP (M. Wt. 40,000; Sigma)
during nucleic acid/lipid complex formation at the time
of transfection.
Nuclease and serum treatment of siRNAs
For limited RNase digestion, 3 ng of Dc9si RNAs (Dc9si)
was incubated with 2 μg/ml RNase A and 0.1 μg/ml RNase
T1 in 15 μl for 15 minutes at room temperature. The reac-
tion was stopped by vortexing with 15 μl Phenol/Chloro-
form and 2 μl of the aqueous phase was analysed by RPA.
Serum treatment of siRNAs was carried out by incubating
3 μl (4.5 ng) of each of Tc9si and Dc9si with 5 μl of FBS at
37°C. Reactions were stopped by adding 10 μl of REB
(100 mM tris pH7.5, 150 mM NaCl, 12.5 mM EDTA, 1%
SDS), followed by Phenol/Chloroform extraction and
ethanol precipitation. The RNA pellet was dissolved in 10
μl depc-treated water and 2 μl (~0.5 ng siRNA) and ana-
lysed by RPA.
Synthetic siRNAs
The sequences of synthetic mouse caspase 9 (c9si) and
EGFP (Esi) siRNAs (Proligo) are as follows. Caspase 9
(c9si, sense, 5'-ggagcagagaguagugaagtt-3'; antisense, 5'-
cuucacuacucucugcucctt-3') and EGFP (Esi, sense, 5'-
gcaagcugacccugaaguucau-3'; anti-sense, 5'-gaacuucagggu-
cagcuugccg-3'). mEsi is identical to Esi except that the 3'
terminal ribonucleotide on both strands is methylated at
the 2 position of the ribose. Dc9si were processed from
~400 nt double-stranded RNA precursors in 15 μl reac-
tions under optimised conditions that were similar to the
suppliers protocol (Stratagene). Using ~200 ng of dsRNA,
1 U of recombinant Dicer and incubation at 37°C over-
night ~80% of the dsRNA was converted to siRNAs using
an optimal amount of Dicer.
Gene silencing assays in mammalian cells
BalbC 3T3 cells in 96-well tissue culture plates were co-
transfected with pmC9-dsEGFP and pdsEGFP (70 ng
each) and test siRNAs samples using Lipofectamine 2000
(Lipo2000, Invitrogen) according to the suppliers proce-
dure. 16 hours after transfection cells from one transfected
well plus one untransfected well (included as carrier to
increase the cell pellet) were washed with PBS, treated
with trypsin at 37°C for 5 minutes, neutralized by addi-
tion of growth medium containing 10% FBS, collected by
centrifugation and washed again with PBS. Cells were
then lysed by addition of 8 μl of cell lysis buffer (20 mM
Tris-Cl, pH 7.5); 50 mM NaCl; 1 mM EDTA, pH 8; 1 mM
EGTA, pH 7; 1% Triton X-100 and supplemented with
complete protease inhibitor cocktail (Roche), centrifuged
at 13000 g for 10 minutes and half of the cell lysate ana-
lysed by Western blot. Membranes were incubated for 1
hour with 1:2000 primary EGFP antibody (mouse mono-
clonal JL8, Clontech) and for 30 minutes with anti-mouse
HRP conjugated secondary antibody (Amersham
NA931). Visualisation was achieved using an ECL detec-
tion kit (Amersham NA931) with typical x-ray film expo-
sure times of less than one minute.
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